Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1999 Apr;75(882):208–212. doi: 10.1136/pgmj.75.882.208

Targeting pneumococcal vaccination to high-risk groups: a feasibility study in one general practice

A Siriwardena
PMCID: PMC1741189  PMID: 10715759

Abstract

The Department of Health recommends pneumococcal vaccination opportunistically or when immunising against influenza. This was a study in one general practice to assess the feasibility of targeting patients for pneumococcal vaccination in primary care. We also examined the rate of uptake of pneumococcal vaccine in identified risk groups after one year of a pneumococcal vaccination programme. A self-administered questionnaire was given to patients attending for influenza vaccine between September and December 1996. A total of 551/747 (73.8%) patients returned completed questionnaires. Few patients receiving influenza vaccination (133/509, 26%) were aware of pneumococcal vaccine. Only 55/108 (51%) of those given influenza vaccination were in a clinical risk group for pneumococcal vaccine. Attitudes towards vaccination were more positive and intention to take up pneumococcal vaccination significantly greater in high-risk patients compared to those who were not in a risk group. A targeted vaccination campaign directed at high-risk patients, both opportunistically and those attending for influenza vaccination over one year, resulted in the following proportions of patients in at-risk groups being vaccinated: coronary disease 144/312 (46%), diabetes 79/132 (60%), splenectomy 2/2 (100%), chronic obstructive airways disease and asthma 135/700 (19%), and chronic renal failure 5/9 (56%). Most doses of pneumococcal vaccine (336/463; 73%) were delivered to patients in high-risk groups. We conclude that a well-organised pneumococcal vaccination campaign can improve coverage of at-risk patients in general practice. Programmes to increase patient awareness of the vaccine, improved availability of vaccine, and practice guidelines, would help to target the vaccine to at-risk patients. Patients with chronic lung disease and asthma were particularly difficult to define and target in this study. A review of the UK guidelines, aligning those for pneumococcal and influenza vaccination and including patients over 65 years, would improve the logistics of vaccine delivery.


Keywords: pneumococcal vaccination; influenza vaccination; primary care; audit

Full Text

The Full Text of this article is available as a PDF (102.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Diguiseppi C. Why everyone over 65 deserves influenza vaccine. BMJ. 1996 Nov 9;313(7066):1162–1162. doi: 10.1136/bmj.313.7066.1162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fedson D. S. Clinical practice and public policy for influenza and pneumococcal vaccination of the elderly. Clin Geriatr Med. 1992 Feb;8(1):183–199. [PubMed] [Google Scholar]
  3. Fedson D., Henrichsen J., Mäkelä P. H., Austrian R. Immunization of elderly people with polyvalent pneumococcal vaccine. Infection. 1989 Nov-Dec;17(6):437–441. doi: 10.1007/BF01645568. [DOI] [PubMed] [Google Scholar]
  4. Fiebach N., Beckett W. Prevention of respiratory infections in adults. Influenza and pneumococcal vaccines. Arch Intern Med. 1994 Nov 28;154(22):2545–2557. [PubMed] [Google Scholar]
  5. Gené J., Espínola A., Cabezas C., Boix C., Comín E., Martin A., Sanz E. Do knowledge and attitudes about influenza and its immunization affect the likelihood of obtaining immunization? Fam Pract Res J. 1992 Mar;12(1):61–73. [PubMed] [Google Scholar]
  6. Hattotuwa K. L., Hind C. R. Pneumococcal vaccine. Postgrad Med J. 1997 Apr;73(858):222–224. doi: 10.1136/pgmj.73.858.222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hinman A. R., Orenstein W. A., Mortimer E. A., Jr When, where, and how do immunizations fail? Ann Epidemiol. 1992 Nov;2(6):805–812. doi: 10.1016/1047-2797(92)90074-z. [DOI] [PubMed] [Google Scholar]
  8. Holt D. M. Recommendations, usage and efficacy of immunizations for the elderly. Nurse Pract. 1992 Mar;17(3):51–59. doi: 10.1097/00006205-199203000-00009. [DOI] [PubMed] [Google Scholar]
  9. Kessner D. M., Kalk C. E., Singer J. Assessing health quality--the case for tracers. N Engl J Med. 1973 Jan 25;288(4):189–194. doi: 10.1056/NEJM197301252880406. [DOI] [PubMed] [Google Scholar]
  10. McDonald P., Friedman E. H., Banks A., Anderson R., Carman V. Pneumococcal vaccine campaign based in general practice. BMJ. 1997 Apr 12;314(7087):1094–1098. doi: 10.1136/bmj.314.7087.1094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nichol K. L., Lind A., Margolis K. L., Murdoch M., McFadden R., Hauge M., Magnan S., Drake M. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med. 1995 Oct 5;333(14):889–893. doi: 10.1056/NEJM199510053331401. [DOI] [PubMed] [Google Scholar]
  12. Obaro S. K., Monteil M. A., Henderson D. C. The pneumococcal problem. BMJ. 1996 Jun 15;312(7045):1521–1525. doi: 10.1136/bmj.312.7045.1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Siriwardena A. N. Clinical guidelines in primary care: a survey of general practitioners' attitudes and behaviour. Br J Gen Pract. 1995 Dec;45(401):643–647. [PMC free article] [PubMed] [Google Scholar]
  14. Siriwardena A. N. Pneumococcal vaccine campaign based in general practice. Expert advice is unclear. BMJ. 1997 Sep 27;315(7111):815–816. [PMC free article] [PubMed] [Google Scholar]
  15. Sisk J. E., Riegelman R. K. Cost effectiveness of vaccination against pneumococcal pneumonia: an update. Ann Intern Med. 1986 Jan;104(1):79–86. doi: 10.7326/0003-4819-104-1-79. [DOI] [PubMed] [Google Scholar]
  16. Watkins J. Effectiveness of influenza vaccination policy at targeting patients at high risk of complications during winter 1994-5: cross sectional survey. BMJ. 1997 Oct 25;315(7115):1069–1070. doi: 10.1136/bmj.315.7115.1069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wiselka M. Influenza: diagnosis, management, and prophylaxis. BMJ. 1994 May 21;308(6940):1341–1345. doi: 10.1136/bmj.308.6940.1341. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES